Two Long Island developers of COVID-19 vaccines are pursuing human trials and developing distribution plans, part of a global effort that one logistics official called humanity’s biggest product launch ever. Partners of Hauppauge-based Covaxx and Farmingdale-based Codagenix Inc., already have begun production of the vaccine candidates in the expectation of successful human trials.

In this episode features David Schull, President of Russo Partners. Here, he discusses his best advice for founding a business, the importance of defining your goals, and more.

From liquid biopsies to precision medicine to immunology, the field of cancer treatment has experienced significant progress during the last decade. Although according to the American Cancer Society more than 80% of those diagnosed with cancer in the United States are 55-years-old or older, many are living longer, full lives despite their disease. Cancer detection […]